ECTRIMS eLearning

The influence of psychomotor therapy on cognitive and motor functioning in MS patients
Author(s):
A.J. Mielnik
,
A.J. Mielnik
Affiliations:
A. Jeszka
,
A. Jeszka
Affiliations:
A. Ogrodniczak
,
A. Ogrodniczak
Affiliations:
R. Rautszko
R. Rautszko
Affiliations:
ECTRIMS Learn. Mielnik A. 09/16/16; 146084; P1657
Aleksandra Mielnik
Aleksandra Mielnik
Contributions
Abstract

Abstract: P1657

Type: LB Poster

Abstract Category: Late Breaking News

Background: Patients with Multiple Sclerosis (MS) face both physical and mental symptoms of illness. In terms of rehabilitation it is important to provide patients with activities that involve motor as well as cognitive activity. Psychomotor Therapy is a holistic approach to a person, it combines physical, emotional, cognitive and social aspects of functioning. The aim of Psychomotor Therapy is to create or activate neuronal networks coordinating integration processes in the brain. That may help in maintaining physical and mental abilities and prolong patient"s independence.

Objective: The aim of the study was to investigate the influence of Psychomotor Therapy on motor and cognitive functioning in MS patients.

Method: 62 patients of MS Rehabilitation Centre in Borne Sulinowo participated in the study. All participants were examined in terms of motor and cognitive functioning. Patients were then randomly assigned to undergo Psychomotor Therapy, (nine sessions over three weeks). At the end of the Therapy all patients underwent another examination to evaluate changes in their functioning. Both evaluations comprised of: Verbal Fluency Test (VFT), Paced Visual Serial Addition Test (PVSAT), Symbol Digit Modalities Test (SDMT), Digit Span Test, Timed 25-foot Walk (T25FW), Timed 25-foot Walk Cognitive (T25FWC) , Up and Go Test (UGT), Up and Go Test Cognitive (UGTC). Demographic data (sex, age, and level of education), disease duration, MS subtype, Expanded Disability Status Scale (EDSS) were also registered.

Results: Experimental group: 33patients (18 women, 15 men), mean age: 47,61 years old, mean disease duration: 12,12years, mean EDSS score: 4,98.

Control group: 29 patients (22 women, 7 men), mean age: 51,69 years old, mean disease duration: 13,95 years, mean EDSS score: 5,58.

In terms of cognitive performance (primary and working memory, verbal fluency and processing speed) no significant intergroup differences were found (5% significance level).

One the other hand participants from the experimental group improved in T25FW, T25FWC, UGT and UGTC as compared to patients from the control group.

Discussion: The lack of intergroup differences in cognitive measures may be caused by insufficient intensity of the Therapy (only 9 meetings over three weeks). However some intergroup differences in mobility and dual task tests may suggest that Psychomotor Therapy can be helpful for MS patients, who want to improve their functional gait abilities combined with cognitive tasks.

Disclosure:

Anna Jeszka: nothing to disclose

Aleksandra Mielnik: nothing to disclose

Anna Ogrodniczak: nothing to disclose

Renata Rautszko: nothing to disclose

Abstract: P1657

Type: LB Poster

Abstract Category: Late Breaking News

Background: Patients with Multiple Sclerosis (MS) face both physical and mental symptoms of illness. In terms of rehabilitation it is important to provide patients with activities that involve motor as well as cognitive activity. Psychomotor Therapy is a holistic approach to a person, it combines physical, emotional, cognitive and social aspects of functioning. The aim of Psychomotor Therapy is to create or activate neuronal networks coordinating integration processes in the brain. That may help in maintaining physical and mental abilities and prolong patient"s independence.

Objective: The aim of the study was to investigate the influence of Psychomotor Therapy on motor and cognitive functioning in MS patients.

Method: 62 patients of MS Rehabilitation Centre in Borne Sulinowo participated in the study. All participants were examined in terms of motor and cognitive functioning. Patients were then randomly assigned to undergo Psychomotor Therapy, (nine sessions over three weeks). At the end of the Therapy all patients underwent another examination to evaluate changes in their functioning. Both evaluations comprised of: Verbal Fluency Test (VFT), Paced Visual Serial Addition Test (PVSAT), Symbol Digit Modalities Test (SDMT), Digit Span Test, Timed 25-foot Walk (T25FW), Timed 25-foot Walk Cognitive (T25FWC) , Up and Go Test (UGT), Up and Go Test Cognitive (UGTC). Demographic data (sex, age, and level of education), disease duration, MS subtype, Expanded Disability Status Scale (EDSS) were also registered.

Results: Experimental group: 33patients (18 women, 15 men), mean age: 47,61 years old, mean disease duration: 12,12years, mean EDSS score: 4,98.

Control group: 29 patients (22 women, 7 men), mean age: 51,69 years old, mean disease duration: 13,95 years, mean EDSS score: 5,58.

In terms of cognitive performance (primary and working memory, verbal fluency and processing speed) no significant intergroup differences were found (5% significance level).

One the other hand participants from the experimental group improved in T25FW, T25FWC, UGT and UGTC as compared to patients from the control group.

Discussion: The lack of intergroup differences in cognitive measures may be caused by insufficient intensity of the Therapy (only 9 meetings over three weeks). However some intergroup differences in mobility and dual task tests may suggest that Psychomotor Therapy can be helpful for MS patients, who want to improve their functional gait abilities combined with cognitive tasks.

Disclosure:

Anna Jeszka: nothing to disclose

Aleksandra Mielnik: nothing to disclose

Anna Ogrodniczak: nothing to disclose

Renata Rautszko: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies